首页> 外文期刊>Radiation oncology >Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer
【24h】

Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer

机译:宫颈癌调强放疗中保留骨髓的最佳剂量限制策略

获取原文
           

摘要

To quantify the dosimetric parameters of different bone marrow sparing strategies and to determine the optimal strategy for cervical cancer patients undergoing postoperative intensity-modulated radiotherapy (IMRT). Fifteen patients with cervical cancer were selected for analysis. The planning target volume (PTV) and the organs at risks (OAR) including small bowel, bladder, rectum, femoral heads, os coxae (OC), lumbosacral spine (LS) and bone marrow (BM) were contoured. For each patient, four IMRT plans with different strategies were generated, including one plan without BM as the dose-volume constraint, namely IMRT (N) plan, and three bone marrow sparing (BMS-IMRT) plans. The three BMS-IMRT plans used the BM, OC, OC and LS respectively, as the BM OAR, namely as IMRT (BM), IMRT (OC) and IMRT (OC?+?LS) plans. Dose volumes for the target and the OARs were compared using analysis of variance (ANOVA). Compared with IMRT (N) plans, the dose to the small bowel, bladder, rectum and femoral heads showed no increase in the three BMS-IMRT plans. However, the irradiated dose to BM, OC and LS significantly decreased. In particular, the mean dose of BM, OC and LS decreased by about 5Gy (p??0.05) in IMRT (BM) plans while the average volume receiving ≥20, ≥30, ≥40Gy decreased by 7.1–24.2%. The LS volume receiving 40Gy showed the highest decrease (about 31.2%, p??0.05) in IMRT (OC?+?LS) plans. On the other hand, in comparison with IMRT (BM), IMRT (OC) reduced the dose volume of to the OC, but increased the dose to LS while IMRT (OC?+?LS) plans reduced both the OC and the LS volume at all dose levels. Specifically, the V20 of OC and LS in the IMRT (OC?+?LS) plan decreased by 11.5 and 11.2%, respectively. By introducing the os coxae and lumbosacral spine as the dose–volume constraints, the IMRT plans exhibited the best sparing of the bone marrow without compromising the dose to surrounding normal structures. Therefore, we recommend adding the os coxae and lumbosacral spine as the BM OAR in such plans.
机译:为了量化不同的保留骨髓策略的剂量学参数,并确定接受术后强度调制放疗(IMRT)的宫颈癌患者的最佳策略。选择15例宫颈癌患者进行分析。概述了计划目标体积(PTV)和高危器官(OAR),包括小肠,膀胱,直肠,股骨头、,骨(OC),腰s骨(LS)和骨髓(BM)。对于每位患者,生成了具有不同策略的四个IMRT计划,包括一个没有BM作为剂量-体积约束的计划,即IMRT(N)计划,以及三个骨髓保留(BMS-IMRT)计划。这三个BMS-IMRT计划分别使用BM,OC,OC和LS作为BM OAR,即IMRT(BM),IMRT(OC)和IMRT(OC ++ LS)计划。使用方差分析(ANOVA)比较目标和OAR的剂量。与IMRT(N)计划相比,三个BMS-IMRT计划对小肠,膀胱,直肠和股骨头的剂量没有增加。但是,对BM,OC和LS的辐照剂量明显降低。特别是,IMRT(BM)计划中BM,OC和LS的平均剂量下降了约5Gy(p <0.05),而接受≥20,≥30,≥40Gy的平均剂量下降了7.1–24.2%。在IMRT(OC2 +ΔLS)计划中,接受40Gy的LS量显示出最大的减少量(约31.2%,p 0.05)。另一方面,与IMRT(BM)相比,IMRT(OC)减少了OC的剂量,但增加了LS的剂量,而IMRT(OC?+?LS)计划减少了OC和LS的体积在所有剂量水平。具体而言,IMRT(OC2 +ΔLS)计划中的OC和LS的V20分别降低了11.5%和11.2%。通过引入co骨和腰s脊椎作为剂量-体积限制,IMRT计划显示出最佳的骨髓保留,而不会影响周围正常结构的剂量。因此,我们建议在此类计划中添加髋臼骨和腰s椎作为BM OAR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号